Can radiomics push the limits of current IPMN malignancy assessment and help avoid unnecessary resection?

Eur Radiol. 2024 Feb;34(2):1219-1221. doi: 10.1007/s00330-023-10225-x. Epub 2023 Sep 22.

Author

Fumihito Toshima¹

Affiliation

¹ Department of Radiology, Kanazawa University Graduate School of Medical Sciences, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-8640, Japan. fumihitotoshima@staff.kanazawa-u.ac.jp.

PMID: 37740085
DOI: 10.1007/s00330-023-10225-x

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Pancreatic Ductal* / pathology
Humans
Neoplasms, Cystic, Mucinous, and Serous*
Pancreatic Intraductal Neoplasms*
Pancreatic Neoplasms* / diagnostic imaging
Pancreatic Neoplasms* / pathology
Pancreatic Neoplasms* / surgery
Radiomics